inVentiv Selling Solutions Selected to Provide Sales Team for Cep... (atements within themeaning of the Privat...)

inVentiv Selling Solutions Selected to Provide Sales Team for Cephalon Inc.

Date:3/6/2008

atements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause inVentiv Health's performance to differ materially. Such risks include, without limitation: changes in trends in the pharmaceutical industry or in pharmaceutical outsourcing; our ability to compete successfully with other services in the market; our ability to maintain large client contracts or to enter into new contracts; uncertainties related to future incentive payments; and, our ability to operate successfully in new lines of business. Readers of this press release are referred to documents filed from time to time by inVentiv Health Inc. with the Securities and Exchange Commission for further discussion of these and other factors.

SOURCE inVentiv Health, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine news :

1. inVentiv Health to Present at the 20th Annual Bear Stearns Healthcare Conference
2. inVentiv Health to Announce Third Quarter Results and Conduct Conference Call on Wednesday, November 7, 2007
3. inVentiv Health Launches Fourth Business Segment: inVentiv Patient Outcomes
4. inVentiv Health to Present at the 2007 Credit Suisse Healthcare Conference
5. inVentiv Health Creates Client Development and Integration Team
6. inVentiv Health Provides Updated Information on December 11th Investor Day
7. inVentiv Health to Announce Fourth Quarter and Full Year 2007 Results and Conduct Conference Call on Thursday, February 28th
8. inVentiv Health Ranked #17 by Training Magazine in its 2008 List of Top 125 Training Companies
9. inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007
10. Federal Trade Commission Attempts To Suppress Best-Selling Authors First Amendment Rights
11. FTC Attacks Infomercial Marketer to Silence Best-Selling Authors Weight-Loss Tips

Post Your Comments:

(Date:12/2/2008)... , Amsterdam, 2 December 2008 - Elsevier announce...tters 2008 Supplement on the theme of "Second tri.... Second trimester abortion raises complex issues...providers of service delivery and the sometimes co... This issue of Reproductive Health Matters grew ...

(Date:12/2/2008)... , , WASHINGTON -- A new report from the Institu...ents, duty hours and workloads to decrease the cha...nce the learning environment for these doctors in ...educing residents, work hours from the maximum ave...il for Graduate Medical Education (ACGME) in 2003,...

(Date:12/2/2008)... , , SAN DIEGO, Dec. 2 S...est-growing exercise program for new moms and thei...r in baby care for more than 40 years, has signed ... , The new partnership will strengthen the com...ers and moms. , , "We are thrilled to have ...

(Date:12/2/2008)... Randomized Comparator Study to Evaluate Efficacy... , , WOODCLIFF LAKE, N.J., Dec. 2 /PRNewswi...nounced that it plans to initiate the first clinic...citabine for injection) compared to Vidaza(R) (aza...ntermediate-2 or high-risk myelodysplastic syndrom...

Breaking Medicine News(10 mins):Health News:Elsevier announces the 2008 supplement of Reproductive Health Matters 2 Health News:Revised hours and workloads for medical residents needed to prevent 2 Health News:Revised hours and workloads for medical residents needed to prevent 3 Health News:Stroller Strides(R) Signs Pampers(R) as Premier Sponsor for 2009 2 Health News:Eisai Will Initiate First Head-to-Head Study Comparing Dacogen(R) (decitabine for injection) and Vidaza(R) (azacitidine) in Patients with Myelodysplastic Syndromes 2 Health News:Eisai Will Initiate First Head-to-Head Study Comparing Dacogen(R) (decitabine for injection) and Vidaza(R) (azacitidine) in Patients with Myelodysplastic Syndromes 3

[0] Elsevier announces the 2008 supplement of Reproductive Health Matters [0] Revised hours and workloads for medical residents needed to prevent [0] Stroller Strides(R) Signs Pampers(R) as Premier Sponsor for 2009 [0] Eisai Will Initiate First Head-to-Head Study Comparing Dacogen(R) (decitabine for injection) and Vidaza(R) (azacitidine) in Patients with Myelodysplastic Syndromes

... of pharmacology; the number of people taking medi...e recent years. It is however to be noted that com...nsequences, including death. // Several medicatio...can interact or work against each other. Patients ...

...een witness to the death of more than half a milli...e south of Russia.// According to the Federal Con... Jan 25 and Feb 1, almost 350,000 birds have died ...akhkent district, and 76,000 at the Makhachkalinsk...

... effective solutions to major problems. This is es...s now been found that addition of white vinegar to...ively destroy bacterial spores. // Researchers fr... this simple yet significant solution to bacterial...

...tution has warned about the possibility of a hemag... constitution of the much-dreaded avian influenza ...could enable human-human bird flu transmission by ...an receptors. The company has also alerted the WH...

Other Medicine News:Health News:Drug Combinations Could Be Dangerous 2 Health News:Genetic Change In The H5N1 Virus Likely: Recombinomics Inc. 2

Drug Combinations Could Be Dangerous Russia Hit by Bird Flu Killing Power Of Bleach Enhanced By Addition Of Vinegar Genetic Change In The H5N1 Virus Likely: Recombinomics Inc.

(Date:12/1/2008)... Dec. 1 GeoVax Labs, Inc...otechnology company developing,human vaccines for...Virus) and,other infectious agents, announced tod...Trials will take place in twelve sites across Nort...n collaboration with The National Institutes of,H...

(Date:11/28/2008)...OLIS, Nov. 28 Eli Lilly ...lemental New Drug Application (sNDA) from,the U.S...R) (duloxetine HCl),for the management of chronic...,the first half of 2009, adding data from a recent...itis pain of the knee. , The decision does ...

(Date:11/25/2008)...awareness can improve recovery , , Audio an...available on the Mayo Clinic News Blog. Please see... , ROCHESTER, Minn., Nov. 25 /PRNewswire-USNew...stroke patients don,t think they,re having a strok...til their condition worsens. The findings appear i...

(Date:11/25/2008)...E, Calif., Nov. 25 Pharm...that the company has completed a Phase 1,clinical...in-class,small-molecule Factor VIIa inhibitor. Th...unteers to evaluate the safety and pharmacologic e...I-27483 resulted in a linear dose,response in the...

[0] GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America [0] Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain [1] Do You Know You're Having a Stroke?[0] Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483

... Reported Safety & Tolerability Profile,in Sub...CHICAGO, June 25 /PRNewswire-FirstCall/ -- Phase I...of the American Diabetes,Association demonstrated ...dase-4 (DPP-4) in development by Bristol-Myers,Squ...), in,combination with metformin, exhibited a stat...

...Unique Mechanism of Action and Broad Potential for...A, Calif., June 26, 2007 (PRIME NEWSWIRE) -- Avige... innovating therapeutics,for the treatment of neur...pinion on Investigational Drugs has published an a...(ibudilast), a potential,first-in-class, non-opioi...

Other Medicine Technology:Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 2 Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 3 Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 4 Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 5 Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 6 Expert Opinion Highlights Avigen's AV411 as Potential New,Therapeutic for Neuropathic Pain and Opioid Withdrawal 2 Expert Opinion Highlights Avigen's AV411 as Potential New,Therapeutic for Neuropathic Pain and Opioid Withdrawal 3 Expert Opinion Highlights Avigen's AV411 as Potential New,Therapeutic for Neuropathic Pain and Opioid Withdrawal 4 Expert Opinion Highlights Avigen's AV411 as Potential New,Therapeutic for Neuropathic Pain and Opioid Withdrawal 5

Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone Expert Opinion Highlights Avigen's AV411 as Potential New,Therapeutic for Neuropathic Pain and Opioid Withdrawal

Indicated for treatment of patella instability

OmoTrain is a unique support for the shoulder that promotes mobility and limits rotation.

... someone suffers an episode of acute low back pain...ickly restores functional mobility by providing po...,With just a few sizes that correspond directly to... will reduce inventory requirements while simplify...

Shoulder Immobilizer with Body Strap Navy blue cotton. Thumb look helps keep hand in neutral position. Padded, 2" blue pile material laminated to foam shoulder and body strap. Fits left or right. 5/p

Medicine Products:

13 Patella Stabilizer w/Cor-Trak Buttress OmoTrain Quickdraw PRO Shoulder Immobilizer with Body Strap

inVentiv Selling Solutions Selected to Provide Sales Team for Cep...(atements within themeaning of the Privat...),Health